tiprankstipranks
Trending News
More News >
Iovance Biotherapeutics Inc (IOVA)
NASDAQ:IOVA
US Market
Advertisement

Iovance Biotherapeutics (IOVA) Ownership - Who Owns Iovance Biotherapeutics?

Compare
3,765 Followers

Iovance Biotherapeutics (IOVA) Ownership Overview

0.32%12.60%20.22%12.07%54.80%
20.22% Other Institutional Investors
12.07% ETFs
54.80% Public Companies and
Individual Investors
The ownership structure of Iovance Biotherapeutics (IOVA) stock is a mix of institutional, retail, and individual investors. Approximately 44.88% of the company’s stock is owned by Institutional Investors, 0.32% is owned by Insiders, and 54.80% is owned by Public Companies and Individual Investors.
The ownership structure of Iovance Biotherapeutics (IOVA) stock is a mix of institutional, retail, and individual investors. Approximately 32.82% of the company’s stock is owned by Institutional Investors, 0.32% is owned by Insiders, and 12.07% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date
Name
Activity
Value
Jun 06, 2025
xxxxxxxxxxxxx
$55200
May 27, 2025
xxxxxxxxxxxxx
$9688
May 16, 2025
xxxxxxxxxxxxx
$42250
Nov 14, 2024
xxxxxxxxxxxxx
$503000

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value
Jun 30, 2025
xxxxxxxxxxxxx
$223600
Jun 30, 2025
xxxxxxxxxxxxx
$976409

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
20,813,308Institution5.75%47,246,209
20,412,208Institution5.64%46,335,712
12,711,788Institution3.51%28,855,759
12,317,021Institution3.40%27,959,638
4,437,542Institution1.23%10,073,220
3,280,195Institution0.91%7,446,043
3,127,377Institution0.86%7,099,146
2,940,670Institution0.81%6,675,321
2,305,331Institution0.64%5,233,101
2,122,721Institution0.59%4,818,577

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
20,412,208Institution5.64%46,335,712
3,280,195Institution0.91%7,446,043
3,127,377Institution0.86%7,099,146
2,940,670Institution0.81%6,675,321
2,305,331Institution0.64%5,233,101
2,122,721Institution0.59%4,818,577
1,640,368Institution0.45%3,723,635
1,475,722Institution0.41%3,349,889
1,139,550Institution0.31%2,586,779
862,468Institution0.24%1,957,802

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
9,671,913Institution2.67%24,856,816
6,355,245Institution1.76%14,426,406
3,691,973Institution1.02%8,934,575
3,646,009Institution1.01%9,370,243
2,697,337Institution0.75%6,932,156
2,340,553Institution0.65%6,015,221
2,213,704Institution0.61%5,025,108
1,650,919Institution0.46%3,747,586
1,209,178Institution0.33%3,107,587
1,155,931Institution0.32%2,797,353

FAQ

Who Owns Iovance Biotherapeutics Inc (IOVA)?
According to the latest TipRanks data, approximately 20.22% of the company's stock is held by institutional investors, 0.32% is held by insiders, and 54.80% is held by retail investors.
    What percentage of Iovance Biotherapeutics Inc (IOVA) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 20.22% of Iovance Biotherapeutics Inc (IOVA) stock is held by institutional investors.
      What percentage of Iovance Biotherapeutics Inc (IOVA) stock is held by retail investors?
      According to the latest TipRanks data, approximately 54.80% of Iovance Biotherapeutics Inc (IOVA) stock is held by retail investors.
        Who owns the most shares of Iovance Biotherapeutics Inc (IOVA)?
        Vanguard owns the most shares of Iovance Biotherapeutics Inc (IOVA).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis